Royal London Asset Management LTD Abb Vie Inc. Transaction History

Royal London Asset Management LTD

$44.9 Billion
Q3 2025

A detailed history of Royal London Asset Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 1,305,274 shares of ABBV stock, worth $305 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

1,305,274

Previous 1,314,058 0.67%

Holding current value

$305 Million

Previous $244 Million 23.91%

% of portfolio

0.67%

Previous 0.58%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$184.85 - $231.54 $1.62 Million - $2.03 Million	-8,784 Reduced 0.67%	1,305,274 $302 Million
Q2 2025 Aug 14, 2025	SELL	$170.16 - $206.27 $7.72 Million - $9.36 Million	-45,381 Reduced 3.34%	1,314,058 $244 Million
Q1 2025 May 13, 2025	BUY	$169.2 - $216.66 $9.17 Million - $11.7 Million	54,217 Added 4.15%	1,359,439 $285 Million
Q4 2024 Feb 11, 2025	SELL	$164.99 - $203.87 $10.9 Million - $13.5 Million	-66,066 Reduced 4.82%	1,305,222 $232 Million
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $2.01 Million - $2.44 Million	12,248 Added 0.9%	1,371,288 $271 Million

Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $17.1 Million - $20 Million	-110,764 Reduced 7.54%	1,359,040 $233 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $15.2 Million - $17.3 Million	94,958 Added 6.91%	1,469,804 $268 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $12.9 Million - $14.5 Million	93,443 Added 7.29%	1,374,846 $213 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $12.3 Million - $14.3 Million	92,201 Added 7.75%	1,281,403 $191 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $25.6 Million - $31.8 Million	193,094 Added 19.38%	1,189,202 $160 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $10 Million - $11.6 Million	69,437 Added 7.49%	996,108 $159 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $2.7 Million - $3.24 Million	19,534 Added 2.15%	926,671 $150 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $6.42 Million - $7.37 Million	-47,868 Reduced 5.01%	907,137 $122 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $427,447 - $543,425	-3,106 Reduced 0.32%	955,005 $147 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $9.72 Million - $12.1 Million	73,637 Added 8.33%	958,111 $155 Million
Q4 2021 Oct 18, 2022	SELL	$107.43 - $135.93 $4.63 Million - $5.86 Million	-43,115 Reduced 4.65%	884,474 $120 Million
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $4.63 Million - $5.86 Million	-43,115 Reduced 4.65%	884,474 $120 Million
Q3 2021 Oct 18, 2022	SELL	$106.4 - $120.78 $2.04 Million - $2.31 Million	-19,163 Reduced 2.02%	927,589 $100 Million
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $2.04 Million - $2.31 Million	-19,163 Reduced 2.02%	927,589 $100 Million
Q2 2021 Oct 18, 2022	SELL	$105.21 - $117.21 $868,298 - $967,334	-8,253 Reduced 0.86%	946,752 $107 Million
Q2 2021 Jul 14, 2021	SELL	$105.21 - $117.21 $2.8 Million - $3.12 Million	-26,631 Reduced 2.74%	946,752 $107 Million
Q1 2021 Oct 17, 2022	BUY	$102.3 - $112.62 $1.88 Million - $2.07 Million	18,378 Added 1.92%	973,383 $105 Million
Q1 2021 Apr 13, 2021	BUY	$102.3 - $112.62 $2.46 Million - $2.71 Million	24,070 Added 2.54%	973,383 $105 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $217,323 - $293,409	2,700 Added 0.29%	949,313 $102 Million
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $1.59 Million - $1.87 Million	18,521 Added 2.0%	946,613 $82.2 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $6.26 Million - $8.38 Million	85,373 Added 10.13%	928,092 $89.5 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $694,213 - $1.05 Million	10,763 Added 1.29%	842,719 $63.4 Million
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $1.23 Million - $1.54 Million	17,052 Added 2.09%	831,956 $73.6 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $396,459 - $476,657	-6,295 Reduced 0.77%	814,904 $61.7 Million
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $389,272 - $497,581	-5,925 Reduced 0.72%	821,199 $59.7 Million
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $2.12 Million - $2.49 Million	27,428 Added 3.43%	827,124 $0
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $12 Million - $14.8 Million	153,773 Added 23.81%	799,696 $72.9 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $2.79 Million - $3.1 Million	-31,357 Reduced 4.63%	645,923 $0
Q2 2018 Sep 19, 2018	BUY	$89.78 - $106.23 $60.8 Million - $71.9 Million	677,280 New	677,280 $62.8 Million

Others Institutions Holding ABBV

# of Institutions

4,488

Shares Held

1.28B

Call Options Held

16.9M

Put Options Held

15.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Abb Vie Inc. Transaction History